Logo image of CHRD

CHORD ENERGY CORP (CHRD) Stock Fundamental Analysis

NASDAQ:CHRD - Nasdaq - US6742152076 - Common Stock - Currency: USD

93.51  -1.4 (-1.48%)

After market: 93.51 0 (0%)

Fundamental Rating

5

Overall CHRD gets a fundamental rating of 5 out of 10. We evaluated CHRD against 212 industry peers in the Oil, Gas & Consumable Fuels industry. CHRD has only an average score on both its financial health and profitability. CHRD has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CHRD had positive earnings in the past year.
CHRD had a positive operating cash flow in the past year.
CHRD had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CHRD had a positive operating cash flow.
CHRD Yearly Net Income VS EBIT VS OCF VS FCFCHRD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B -3B

1.2 Ratios

Looking at the Return On Assets, with a value of 6.49%, CHRD is in the better half of the industry, outperforming 66.04% of the companies in the same industry.
The Return On Equity of CHRD (9.71%) is comparable to the rest of the industry.
CHRD has a Return On Invested Capital (7.29%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for CHRD is significantly below the industry average of 25.76%.
The last Return On Invested Capital (7.29%) for CHRD is well below the 3 year average (15.70%), which needs to be investigated, but indicates that CHRD had better years and this may not be a problem.
Industry RankSector Rank
ROA 6.49%
ROE 9.71%
ROIC 7.29%
ROA(3y)16.4%
ROA(5y)-22.23%
ROE(3y)23.16%
ROE(5y)-60.5%
ROIC(3y)15.7%
ROIC(5y)15.04%
CHRD Yearly ROA, ROE, ROICCHRD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

The Profit Margin of CHRD (16.10%) is better than 64.62% of its industry peers.
In the last couple of years the Profit Margin of CHRD has declined.
CHRD has a Operating Margin (20.62%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CHRD has grown nicely.
The Gross Margin of CHRD (51.05%) is comparable to the rest of the industry.
CHRD's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 20.62%
PM (TTM) 16.1%
GM 51.05%
OM growth 3Y-17.8%
OM growth 5Y20.31%
PM growth 3Y-7.34%
PM growth 5YN/A
GM growth 3Y-4.26%
GM growth 5Y-3.06%
CHRD Yearly Profit, Operating, Gross MarginsCHRD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CHRD is creating some value.
CHRD has more shares outstanding than it did 1 year ago.
CHRD has less shares outstanding than it did 5 years ago.
CHRD has a worse debt/assets ratio than last year.
CHRD Yearly Shares OutstandingCHRD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CHRD Yearly Total Debt VS Total AssetsCHRD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.70, we must say that CHRD is in the distress zone and has some risk of bankruptcy.
CHRD has a Altman-Z score of 1.70. This is in the better half of the industry: CHRD outperforms 61.32% of its industry peers.
CHRD has a debt to FCF ratio of 3.20. This is a good value and a sign of high solvency as CHRD would need 3.20 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.20, CHRD is in the better half of the industry, outperforming 75.94% of the companies in the same industry.
A Debt/Equity ratio of 0.10 indicates that CHRD is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.10, CHRD is in the better half of the industry, outperforming 77.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 3.2
Altman-Z 1.7
ROIC/WACC0.71
WACC10.32%
CHRD Yearly LT Debt VS Equity VS FCFCHRD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 0.94 indicates that CHRD may have some problems paying its short term obligations.
CHRD's Current ratio of 0.94 is on the low side compared to the rest of the industry. CHRD is outperformed by 61.32% of its industry peers.
A Quick Ratio of 0.88 indicates that CHRD may have some problems paying its short term obligations.
CHRD has a Quick ratio (0.88) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.88
CHRD Yearly Current Assets VS Current LiabilitesCHRD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

CHRD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.89%.
CHRD shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.52% yearly.
The Revenue has grown by 34.76% in the past year. This is a very strong growth!
CHRD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.44% yearly.
EPS 1Y (TTM)-16.89%
EPS 3Y1.52%
EPS 5YN/A
EPS Q2Q%-33.52%
Revenue 1Y (TTM)34.76%
Revenue growth 3Y49.24%
Revenue growth 5Y20.44%
Sales Q2Q%50.79%

3.2 Future

Based on estimates for the next years, CHRD will show a decrease in Earnings Per Share. The EPS will decrease by -3.28% on average per year.
Based on estimates for the next years, CHRD will show a decrease in Revenue. The Revenue will decrease by -1.03% on average per year.
EPS Next Y-33.38%
EPS Next 2Y-15.06%
EPS Next 3Y-6.17%
EPS Next 5Y-3.28%
Revenue Next Year-6.18%
Revenue Next 2Y-2.74%
Revenue Next 3Y-1.03%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CHRD Yearly Revenue VS EstimatesCHRD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
CHRD Yearly EPS VS EstimatesCHRD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 10 20 30

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.61, the valuation of CHRD can be described as very cheap.
Based on the Price/Earnings ratio, CHRD is valued cheaper than 83.49% of the companies in the same industry.
CHRD is valuated cheaply when we compare the Price/Earnings ratio to 28.98, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 8.41, the valuation of CHRD can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CHRD indicates a somewhat cheap valuation: CHRD is cheaper than 72.17% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CHRD to the average of the S&P500 Index (21.38), we can say CHRD is valued rather cheaply.
Industry RankSector Rank
PE 5.61
Fwd PE 8.41
CHRD Price Earnings VS Forward Price EarningsCHRD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHRD is valued cheaply inside the industry as 85.85% of the companies are valued more expensively.
CHRD's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 21.14
EV/EBITDA 2.95
CHRD Per share dataCHRD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100

4.3 Compensation for Growth

CHRD's earnings are expected to decrease with -6.17% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.06%
EPS Next 3Y-6.17%

5

5. Dividend

5.1 Amount

CHRD has a Yearly Dividend Yield of 5.33%, which is a nice return.
CHRD's Dividend Yield is a higher than the industry average which is at 7.32.
Compared to an average S&P500 Dividend Yield of 2.46, CHRD pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.33%

5.2 History

CHRD has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CHRD Yearly Dividends per shareCHRD Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 5 10 15 20 25

5.3 Sustainability

62.70% of the earnings are spent on dividend by CHRD. This is not a sustainable payout ratio.
DP62.7%
EPS Next 2Y-15.06%
EPS Next 3Y-6.17%
CHRD Yearly Income VS Free CF VS DividendCHRD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B
CHRD Dividend Payout.CHRD Dividend Payout, showing the Payout Ratio.CHRD Dividend Payout.PayoutRetained Earnings

CHORD ENERGY CORP

NASDAQ:CHRD (4/29/2025, 6:00:42 PM)

After market: 93.51 0 (0%)

93.51

-1.4 (-1.48%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-25 2025-02-25/amc
Earnings (Next)05-06 2025-05-06/amc
Inst Owners90.51%
Inst Owner ChangeN/A
Ins Owners0.59%
Ins Owner Change-10.28%
Market Cap5.56B
Analysts80.87
Price Target144.78 (54.83%)
Short Float %3.76%
Short Ratio2.18
Dividend
Industry RankSector Rank
Dividend Yield 5.33%
Yearly Dividend10.46
Dividend Growth(5Y)N/A
DP62.7%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-11 2025-03-11 (1.3)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.01%
Min EPS beat(2)-11.89%
Max EPS beat(2)21.92%
EPS beat(4)2
Avg EPS beat(4)1.45%
Min EPS beat(4)-11.89%
Max EPS beat(4)21.92%
EPS beat(8)4
Avg EPS beat(8)5.28%
EPS beat(12)5
Avg EPS beat(12)1.63%
EPS beat(16)9
Avg EPS beat(16)10.7%
Revenue beat(2)2
Avg Revenue beat(2)13.41%
Min Revenue beat(2)9.22%
Max Revenue beat(2)17.6%
Revenue beat(4)4
Avg Revenue beat(4)21.72%
Min Revenue beat(4)9.22%
Max Revenue beat(4)36.47%
Revenue beat(8)8
Avg Revenue beat(8)22.75%
Revenue beat(12)12
Avg Revenue beat(12)34.51%
Revenue beat(16)16
Avg Revenue beat(16)36.68%
PT rev (1m)-14.52%
PT rev (3m)-19.42%
EPS NQ rev (1m)2.18%
EPS NQ rev (3m)12.58%
EPS NY rev (1m)-12.02%
EPS NY rev (3m)-20.62%
Revenue NQ rev (1m)8.71%
Revenue NQ rev (3m)4.53%
Revenue NY rev (1m)-2.4%
Revenue NY rev (3m)-1.93%
Valuation
Industry RankSector Rank
PE 5.61
Fwd PE 8.41
P/S 1.06
P/FCF 21.14
P/OCF 2.65
P/B 0.64
P/tB 0.68
EV/EBITDA 2.95
EPS(TTM)16.68
EY17.84%
EPS(NY)11.11
Fwd EY11.88%
FCF(TTM)4.42
FCFY4.73%
OCF(TTM)35.25
OCFY37.7%
SpS88.27
BVpS146.28
TBVpS137.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.49%
ROE 9.71%
ROCE 9.54%
ROIC 7.29%
ROICexc 7.31%
ROICexgc 7.67%
OM 20.62%
PM (TTM) 16.1%
GM 51.05%
FCFM 5.01%
ROA(3y)16.4%
ROA(5y)-22.23%
ROE(3y)23.16%
ROE(5y)-60.5%
ROIC(3y)15.7%
ROIC(5y)15.04%
ROICexc(3y)17%
ROICexc(5y)16.36%
ROICexgc(3y)17.12%
ROICexgc(5y)16.47%
ROCE(3y)20.55%
ROCE(5y)19.7%
ROICexcg growth 3Y-34.65%
ROICexcg growth 5Y32.44%
ROICexc growth 3Y-35.69%
ROICexc growth 5Y31.18%
OM growth 3Y-17.8%
OM growth 5Y20.31%
PM growth 3Y-7.34%
PM growth 5YN/A
GM growth 3Y-4.26%
GM growth 5Y-3.06%
F-Score4
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 3.2
Debt/EBITDA 0.38
Cap/Depr 165.57%
Cap/Sales 34.93%
Interest Coverage 21.87
Cash Conversion 95.73%
Profit Quality 31.13%
Current Ratio 0.94
Quick Ratio 0.88
Altman-Z 1.7
F-Score4
WACC10.32%
ROIC/WACC0.71
Cap/Depr(3y)173.67%
Cap/Depr(5y)227.89%
Cap/Sales(3y)27.34%
Cap/Sales(5y)32.88%
Profit Quality(3y)53.44%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.89%
EPS 3Y1.52%
EPS 5YN/A
EPS Q2Q%-33.52%
EPS Next Y-33.38%
EPS Next 2Y-15.06%
EPS Next 3Y-6.17%
EPS Next 5Y-3.28%
Revenue 1Y (TTM)34.76%
Revenue growth 3Y49.24%
Revenue growth 5Y20.44%
Sales Q2Q%50.79%
Revenue Next Year-6.18%
Revenue Next 2Y-2.74%
Revenue Next 3Y-1.03%
Revenue Next 5YN/A
EBIT growth 1Y-15.12%
EBIT growth 3Y22.68%
EBIT growth 5Y44.91%
EBIT Next Year114.13%
EBIT Next 3Y28.93%
EBIT Next 5Y22.79%
FCF growth 1Y-52.38%
FCF growth 3Y33.26%
FCF growth 5Y149.9%
OCF growth 1Y15.24%
OCF growth 3Y31.89%
OCF growth 5Y18.62%